![Jan Albert Olsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jan Albert Olsson
Président chez
COS Systems AB
Profil
Jan Albert Olsson is currently the Chairman at COS Systems AB. He previously served as the Chief Executive Officer at Uminova Invest AB. He was also the Chairman at Likvor AB in 2011, Chairman at Umecrine AB, Chairman at Probac AB, and Director at Z-forestab AB. Mr. Olsson received his undergraduate degree from Umea Universitet in 1973.
Postes actifs de Jan Albert Olsson
| Sociétés | Poste | Début |
|---|---|---|
COS Systems AB
 COS Systems AB Packaged SoftwareTechnology Services Develops software and IT solutions for planning and operating fiber networks | Président | - |
Anciens postes connus de Jan Albert Olsson
| Sociétés | Poste | Fin |
|---|---|---|
Likvor AB
 Likvor AB Medical SpecialtiesHealth Technology Provides medical devices for neurological investigations | Président | 29/11/2011 |
Uminova Invest AB
 Uminova Invest AB Investment ManagersFinance Uminova Invest specializes in seed capital investing. The firm invests exclusively in high-growth projects and businesses with a clear connection to Umeå University or other academic entities and research institutes in the province of Västerbotten, where Umeå is located. Uminova Invest targets science-based projects with unique selling points and significant market potential, in sectors such as biotechnology, IT and medical technology. The firm acquires minority stakes and typically co-invests with their shareholding institutions. In addition to capital they actively contribute business know-how, management support, marketing expertise and access to their network of contacts. They invest primarily in early-stage companies, and may invest during the growth phase as well. Although they aim to exit their investments after three years once their portfolio companies have an established market, Uminova Invest may retain their stake over the longer term. Their preferred exit strategy is through resale, either to the founder or to existing shareholders. | President | 01/10/2010 |
Z-forestab AB
 Z-forestab AB Trucks/Construction/Farm MachineryProducer Manufacturing Provides cranes, grapples and bush cutter | Directeur/Membre du Conseil | - |
Umecrine AB
 Umecrine AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pharmaceutical company that develops novel class of drugs to treat neurological disorders | Président | - |
Probac AB
 Probac AB Pharmaceuticals: MajorHealth Technology Manufactures, markets, and licenses probiotic products | Président | - |
Formation de Jan Albert Olsson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Umea Universitet
 Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uminova Invest AB
Uminova Invest AB Investment ManagersFinance Uminova Invest specializes in seed capital investing. The firm invests exclusively in high-growth projects and businesses with a clear connection to Umeå University or other academic entities and research institutes in the province of Västerbotten, where Umeå is located. Uminova Invest targets science-based projects with unique selling points and significant market potential, in sectors such as biotechnology, IT and medical technology. The firm acquires minority stakes and typically co-invests with their shareholding institutions. In addition to capital they actively contribute business know-how, management support, marketing expertise and access to their network of contacts. They invest primarily in early-stage companies, and may invest during the growth phase as well. Although they aim to exit their investments after three years once their portfolio companies have an established market, Uminova Invest may retain their stake over the longer term. Their preferred exit strategy is through resale, either to the founder or to existing shareholders. | Finance |
Likvor AB
Likvor AB Medical SpecialtiesHealth Technology Provides medical devices for neurological investigations | Health Technology |
Umecrine AB
Umecrine AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pharmaceutical company that develops novel class of drugs to treat neurological disorders | Commercial Services |
Probac AB
Probac AB Pharmaceuticals: MajorHealth Technology Manufactures, markets, and licenses probiotic products | Health Technology |
Z-forestab AB
Z-forestab AB Trucks/Construction/Farm MachineryProducer Manufacturing Provides cranes, grapples and bush cutter | Producer Manufacturing |
COS Systems AB
COS Systems AB Packaged SoftwareTechnology Services Develops software and IT solutions for planning and operating fiber networks | Technology Services |
